Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wonder if Lexaria will Halt when it announces its uplisting? IMO, it's a huge material change for the company, bigger than a study being done by BTI (which halted the stock).
Interesting to still watch Hill St.s progress with drinks and I hope they do well but I'm glad we've sold the Recreational THC licensing rights. Pharma and tobacco are now our main sectors and CBD remains a growing revenue stream for us.
oh, the other name!
I just fully explained why you are wrong (see posts below) and now you want to start from scratch and I'm hilarious? Get your head out of the sand dude. I'm done with your trolling. No Luck to you.
Lexaria sold the rights to "license DehydraTECH with THC" to Hill Street Beverages. Hill Street wouldn't have paid Lexaria 3.8 million dollars for a process they can't even license to anyone. That's because they can license it because it doesn't need a Health Canada License.
Face it, you're just fear mongering. This is a new market for infused beverages and although DehydraTECH isn't on the shelves in Canada yet it will be soon. The US products show it's a perfectly safe process. Show me where DehydraTECH was approved in the US! You can't, because it didn't have to be there either.
There is no final clearance of DehydraTECH required. It's a process that doesn't require licensing. Also, DehydraTECH is already being used in other products such as 1906 chocolates and their THC pills, also in Cannadips CBD pouches.
Stay tuned, Hill St. will be putting DehydraTECH to use ASAP.
Terry Donnelly recently answered questions on the Hill St. board at CEO.CA regarding using DehydraTECH.
Read and Learn!
http://cdn.ceo.ca.s3-us-west-2.amazonaws.com/1fre0ja-Terry%20CEOca%20Nov%2019%202020.pdf
Call Chris Bunka or Terry Donnelly and they'll agree with me, not you. As far as spelling goes, you said there is a lack of common sense on the board, I agree and posted an example.
Like knowing how to spell nicotine!
For starters, Terry Donnelly, the CEO of Hill St. told me as much in an email conversation I had with him a few months back and it's common knowledge re: cannabis licenses.
DehydraTECH doesn't need a license. Hill Street just needs a licensed place where they can infuse it. Anywhere that has a cannabis processing license from Health Canada is good to go with DehydraTECH. Health Canada licenses are for the building itself. Once you have the processing license for your building you can make what ever Cannabis edible/drink you want using whatever process you want.
Hill Street happens to have at least three of these places (licensed co-packers) where they can start using DehydraTECH with their drinks as they get released.
Hill Street will be using DehydraTECH for all their drinks and powders as soon as possible. Now that Terry has the full rights to have DehydraTECH powder made wherever he wants in Canada or the US he can make deals with co-packers to make powder at their facilities without having to go through Lexaria. The future could still see some co-packers switching to DeHydraTECH, including Molecule.
Lexaria at LD Micro 11:00 ET
https://ve.mysequire.com/
No word yet on BAT but other catalysts are:
Soon to be released European CBD Blood Pressure study, quarterly financials and NASDAQ uplisting date.
Regardless of how any of us on this board feel, CBD sales across the US appear to be accelerating at a huge rate. Here's some stats on that:
https://www.statista.com/statistics/760498/total-us-cbd-sales/
Guessing it's helping more people than not.
Perhaps no one reads this board anymore and has just missed your question. I mean, the board has lost a lot of appeal lately. No one has either confirmed or denied your observation since you asked. Strange.
What did Chris say about it?
The fact that Terry Donnelly of Hill Street believes in Lexaria's tech so strongly has likely done more to get Lexaria recognized as a legitimate technology than any other source including perhaps even Lexaria themselves.
The SP is still below where Lexaria's SP really started to get some traction a few years ago. If the SP is manipulated below that level they won't get many sellers like you said. They need to keep going higher and higher to fish out the weak hands. Also, as with all companies, the more shares any individual has, the easier it is to manipulate those prices. That's why it's so important to make them come to us! Lexaria is a strong company that will eventually not have trouble finding buyers willing to pay way more than the current price.
Lexaria has had good and bad luck but one thing remains true in my mind and that's the company has always done a great job at doing what they've said they would. Other companies haven't stepped up as clients as much as we all would have liked but all Lexaria's work has been above average in my books. Chris and the others haven't sold any shares and they run a tight ship. It's just a matter of time before they hit the big times.
Hopefully up-listing helps to get rid of the liquidity problem. Obviously a deal so big that even shareholders agree it's "Massive" would be good.
I agree that the buyers and sellers are always the same bunch of financial companies that are way too closely interconnected. That does seem obvious. IMO it's almost impossible to know why though. Whatever the reason, I hope it helps the SP go up. Sorry for being difficult but I am skeptical by nature and curious about what others think.
So basically you have no idea then?
Please spell it out how Altria could illegally buy out Lexaria?
Altria is not an "Insider" and currently, "Insiders" are in a buy/sell blackout because of the up-listing.
If Altria was to start accumulating shares, they would have to make a legal filing at 5% ownership of common shares. Have they made this filing?
"Schedule 13D: This form is also known as the Beneficial Ownership Report. Anyone who owns more than 5% of a company's stock must file Form 13D with the SEC within 10 days of a stock acquisition. The form must also include the reason behind the stock acquisition—whether it's a merger, company acquisition, or takeover."
Terry would love that...NOT
6,031,363 restricted common shares of Hill Street at a deemed price of $0.0829 per share as the first required equity-based payment
Apparently doing well on our Hill Street shares already. Up .05 for 6M shares. $300K since the deal already :)
Lexaria closes THC deal with Hill Street
https://ir.lexariabioscience.com/news-events/press-releases/detail/110/lexaria-closes-sale-of-non-pharmaceutical-thc-related-assets
Pretty sure they're trying to get out of the "selling products" market. I would guess we won't be seeing ChrgD+ for much longer.
Lexaria is doing right to completely move away from this way of doing business and investing more time and energy in the licensing and royalty business. It's already happened with other products they've failed to unload at high volumes and I'll be glad to see the end of them.
Let Cannadips and Hill Street and other more savvy marketers do this work and collect royalties from them.
Lexaria needs to focus on Pharma and Nicotine, not BS 70% BF deals.
Altria's deal was through the sub because they were getting some ownership of the sub but so far the BAT deal is not like that.
I agree it's for Nicotine Products but I'm not convinced the study itself is through the Nicotine Subsidiary.
Exactly...Lexaria Bioscience, not Lexaria Nicotine. I also asked Chris which Subsidiary the BAT study was with and he said he couldn't give me any details but it was with Lexaria Bioscience.
Companies should be interested in acquiring Lexaria. It's got huge potential in many of different markets. I would like to see them get more licenses and royalties first as even twice the current SP would not make me happy!
There isn't a specific nicotine patent. The patents are mixed for all sorts of uses. Read the main US Patent News Release here.
https://www.lexariabioscience.com/news/lexaria-bioscience-receives-u-s-patent-award-dehydratechtm-delivery-thc-nsaids-nicotine-vitamins/
Unless Altria bought the entire Lexaria Bioscience company, they would not receive any patents. The patents are part of the core of the company, not part of a subsidiary.
The BAT deal has never been disclosed to be with a specific sub.
I guess that would make sense that Altria could buy the rights to license Oral Nicotine with DehydraTECH and collect royalties in the same way as Hill St. does with THC. With British American Tobacco currently doing studies though, it may be an insult to them to sell the licensing rights for the subsidiary before letting them finish their study.
It could happen I suppose. I would prefer we collect some good license and royalty money before the Nicotine Div. gets sold.
Hill St. just bought the rights to license and collect royalties from Recreational THC, not a core holding. They received no shares from the treasury. Also, Hill St. didn't get patents with their deal.
The Nicotine Division has no clients besides Altria and if they made a deal similar to Hill St's deal they wouldn't get any shares or patents either.
All that being said though, I agree with your observation that someone appears to be amassing shares, perhaps for takeover reasons. The way the accumulators are flocking together is definitely too close for comfort.